Quarterly report pursuant to Section 13 or 15(d)

BASIS OF PRESENTATION (Details Narrative)

v3.21.2
BASIS OF PRESENTATION (Details Narrative)
3 Months Ended
Jul. 17, 2019
shares
Mar. 31, 2020
USD ($)
Mar. 31, 2019
USD ($)
Variable Interest Entity [Line Items]      
Net decrease to cash flow used by operating activities   $ 1,808,000 $ (1,179,000)
Restatement Adjustment [Member]      
Variable Interest Entity [Line Items]      
Net decrease to cash flow used by operating activities     105,000
Restatement Adjustment [Member] | EJ Holding, Inc. [Member]      
Variable Interest Entity [Line Items]      
Net decrease to cash flow used by operating activities     $ (105,000)
Emmaus Life Sciences, Inc. [Member]      
Variable Interest Entity [Line Items]      
Reverse stock split 1-for-6    
Reverse stock split, conversion ratio 0.167    
Telemynd [Member]      
Variable Interest Entity [Line Items]      
Common stock shares, Stock split ratio | shares 1